Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innospec (IOSP) Common Equity (2016 - 2025)

Innospec (IOSP) has disclosed Common Equity for 16 consecutive years, with $1.3 billion as the latest value for Q4 2025.

  • Quarterly Common Equity rose 9.49% to $1.3 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 billion through Dec 2025, up 9.49% year-over-year, with the annual reading at $1.3 billion for FY2025, 9.49% up from the prior year.
  • Common Equity hit $1.3 billion in Q4 2025 for Innospec, up from $1.3 billion in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $1.3 billion in Q4 2025 to a low of $959.1 million in Q1 2021.
  • Historically, Common Equity has averaged $1.1 billion across 5 years, with a median of $1.1 billion in 2023.
  • Biggest YoY gain for Common Equity was 11.45% in 2022; the steepest drop was 0.72% in 2022.
  • Year by year, Common Equity stood at $1.0 billion in 2021, then grew by 0.72% to $1.0 billion in 2022, then increased by 10.5% to $1.1 billion in 2023, then grew by 5.36% to $1.2 billion in 2024, then increased by 9.49% to $1.3 billion in 2025.
  • Business Quant data shows Common Equity for IOSP at $1.3 billion in Q4 2025, $1.3 billion in Q3 2025, and $1.3 billion in Q2 2025.